Emerging paradigms and questions on pro-angiogenic bone marrow-derived myelomonocytic cells

International Journal of Developmental Biology

Volumn 55, Issue 4-5, 2011, Pages 524-534

  Laurent, Julien ^a   Touvrey, Cédric ^a   Botta, Francesca ^a   Kuonen, François ^a,b   Ruegg, Curzio ^a,b,c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b EPFL   (Switzerland)

^c UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Angiogenesis; Bone marrow derived cell; Cancer; Inflammation; Myelomonocytic cell

Indexed keywords

ANGIOPOIETIN RECEPTOR; BISPHOSPHONIC ACID DERIVATIVE; CD11B ANTIGEN; CD133 ANTIGEN; CD146 ANTIGEN; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CTCE 9908; CYCLOOXYGENASE 2; CYTOKINE; ETANERCEPT; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PLERIXAFOR; RCP 169; REACTIVE OXYGEN METABOLITE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; STEM CELL ANTIGEN 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; ZOLEDRONIC ACID;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CANCER INHIBITION; CELL SUBPOPULATION; COLON POLYPOSIS; ENDOTHELIAL PROGENITOR CELL; HUMAN; MONOCYTE; MULTIPLE CANCER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SOLID TUMOR; SUPPRESSOR CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; ANIMAL; ANOXIA; BIOLOGICAL MODEL; GRANULOCYTE PRECURSOR; INFLAMMATION; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VASCULARIZATION;

ANIMALS; ANOXIA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BONE MARROW CELLS; GRANULOCYTE PRECURSOR CELLS; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; MONOCYTES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 79961066993     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.103228jl     Document Type: Article

References (50)

1. APTE, R. N., DOTAN, S., ELKABETS, M., WHITE, M. R., REICH, E., CARMI, Y., SONG, X., DVOZKIN, T., KRELIN, Y. and VORONOV, E. (2006). The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev. 25: 387-408.
2. ASAHARA, T., MUROHARA, T., SULLIVAN, A., SILVER, M., VAN DER ZEE, R., LI, T., WITZENBICHLER, B., SCHATTEMAN, G. and ISNER, J. M. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275: 964-967.
3. BAIS, C., WU, X., YAO, J., YANG, S., CRAWFORD, Y., MCCUTCHEON, K., TAN, C., KOLUMAM, G., VERNES, J. M., EASTHAM-ANDERSON, J., et al. (2010). PlGF blockade does not inhibit angiogenesis during primary tumor growth. Cell. 141: 166-177.
4. BALKWILL, F. (2004). Cancer and the chemokine network. Nat Rev Cancer. 4: 540-550.
5. BALKWILL, F. (2009). Tumour necrosis factor and cancer. Nat Rev Cancer. 9: 361-371.
6. COFFELT, S. B., LEWIS, C. E., NALDINI, L., BROWN, J. M., FERRARA, N. and DE PALMA, M. (2010). Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors. Am J Pathol. 176: 1564-1576.
7. CONEJO-GARCIA, J. R., BENENCIA, F., COURREGES, M. C., KANG, E., MOHAMED-HADLEY, A., BUCKANOVICH, R. J., HOLTZ, D. O., JENKINS, A., NA, H., ZHANG, L., WAGNER, D. S., KATSAROS, D., CAROLL, R. and COUKOS, G. (2004). Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat Med. 10: 950-958.
8. CRIVELLATO, E., NICO, B. and RIBATTI, D. (2008). Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis. Cancer Lett. 269: 1-6.
9. DE PALMA, M., VENNERI, M. A., GALLI, R., SERGI SERGI, L., POLITI, L. S., SAMPAOLESI, M. and NALDINI, L. (2005). Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell. 8: 211-226.
10. DINARELLO, C. A. (2010). Why not treat human cancer with interleukin-1 blockade? Cancer Metastasis Rev. 29: 317-329.
11. DIRKX, A. E., OUDE EGBRINK, M. G., WAGSTAFF, J. and GRIFFIOEN, A. W. (2006). Monocyte/macrophage infiltration in tumors: modulators of angiogenesis. J Leukoc Biol. 80: 1183-1196.
12. FISCHER, C., JONCKX, B., MAZZONE, M., ZACCHIGNA, S., LOGES, S., PATTARINI, L., CHORIANOPOULOS, E., LIESENBORGHS, L., KOCH, M., DE MOL, M., et al. (2007). Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell. 131: 463-475.
13. FRIDLENDER, Z. G., SUN, J., KIM, S., KAPOOR, V., CHENG, G., LING, L., WORTHEN, G. S. and ALBELDA, S. M. (2009). Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell. 16: 183-194.
14. GABRILOVICH, D. I. and NAGARAJ, S. (2009). Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 9: 162-174.
15. GIACCIA, A. J., SIMON, M. C. and JOHNSON, R. (2004). The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease. Genes Dev. 18: 2183-2194.
16. GIRAUDO, E., INOUE, M. and HANAHAN, D. (2004). An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest. 114: 623-633.
17. HASMIM, M., BIELER, G. and RUEGG, C. (2007). Zoledronate inhibits endothelial cell adhesion, migration and survival through the suppression of multiple, prenylation-dependent signaling pathways. J Thromb Haemost. 5: 166-173.
18. HEISSIG, B., HATTORI, K., DIAS, S., FRIEDRICH, M., FERRIS, B., HACKETT, N. R., CRYSTAL, R. G., BESMER, P., LYDEN, D., MOORE, M. A., WERB, Z. and RAFII, S. (2002). Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 109: 625-637.
19. JIN, D. K., SHIDO, K., KOPP, H. G., PETIT, I., SHMELKOV, S. V., YOUNG, L. M., HOOPER, A. T., AMANO, H., AVECILLA, S. T., HEISSIG, B. et al. (2006). Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med. 12: 557-567.
20. KARIN, M. and GRETEN, F. R. (2005). NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 5: 749-759.
21. KARIN, M., LAWRENCE, T. and NIZET, V. (2006). Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell. 124: 823-835.
22. KERBEL, R. S. (2008). Tumor angiogenesis. N Engl J Med. 358: 2039-2049.
23. KIM, S., TAKAHASHI, H., LIN, W. W., DESCARGUES, P., GRIVENNIKOV, S., KIM, Y., LUO, J. L. and KARIN, M. (2009). Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature. 457: 102-106.
24. KIOI, M., VOGEL, H., SCHULTZ, G., HOFFMAN, R. M., HARSH, G. R. and BROWN, J. M. (2010). Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest. 120: 694-705.
25. KUSMARTSEV, S. and GABRILOVICH, D. I. (2006). Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol Immunother. 55: 237-245.
26. LAURENT J, HULL EF, TOUVREY C, KUONEN F, LAN Q, LORUSSO G, DOUCEY MA, CIARLONI L, IMAIZUMI N, ALGHISI GC et al. (2011). Proangiogenic Factor PlGF Programs CD11b+ Myelomonocytes in Breast Cancer during Differentiation of Their Hematopoietic Progenitors. Cancer Res. 71: 3781-3791.
27. LIAO, D. and JOHNSON, R. S. (2007). Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev. 26: 281-290.
28. LIN, E. Y., NGUYEN, A. V., RUSSELL, R. G. and POLLARD, J. W. (2001). Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med. 193: 727-740.
29. LORUSSO, G. and RÜEGG, C. (2008). The tumor microenvironment and its contribution to tumor evolution toward metastasi. Histochem Cell Biol.
30. MANTOVANI, A., ALLAVENA, P., SICA, A. and BALKWILL, F. (2008). Cancer-related inflammation. Nature. 454: 436-444.
31. MURDOCH, C., MUTHANA, M., COFFELT, S. B. and LEWIS, C. E. (2008). The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer. 8: 618-631.
32. MURDOCH, C., TAZZYMAN, S., WEBSTER, S. and LEWIS, C. E. (2007). Expression of Tie-2 by human monocytes and their responses to angiopoietin-2. J Immunol. 178: 7405-7411.
33. NAGARAJ, S., GUPTA, K., PISAREV, V., KINARSKY, L., SHERMAN, S., KANG, L., HERBER, D. L., SCHNECK, J. and GABRILOVICH, D. I. (2007). Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med. 13: 828-835.
34. OCHOA, A. C., ZEA, A. H., HERNANDEZ, C. and RODRIGUEZ, P. C. (2007). Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin Cancer Res. 13: 721s-726s.
35. PASSLICK, B., FLIEGER, D. and ZIEGLER-HEITBROCK, H. W. (1989). Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood. 74: 2527-2534.
36. PETIT, I., JIN, D. and RAFII, S. (2007). The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol. 28: 299-307.
37. POLLARD, J. W. (2009). Trophic macrophages in development and disease. Nat Rev Immunol. 9: 259-270.
38. PUCCI, F., VENNERI, M. A., BIZIATO, D., NONIS, A., MOI, D., SICA, A., DI SERIO, C., NALDINI, L. and DE PALMA, M. (2009). A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood. 114: 901-914.
39. REDJAL, N., CHAN, J. A., SEGAL, R. A. and KUNG, A. L. (2006). CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas. Clin Cancer Res. 12: 6765-6771.
40. RICCIARDI, A., ELIA, A. R., CAPPELLO, P., PUPPO, M., VANNI, C., FARDIN, P., EVA, A., MUNROE, D., WU, X., GIOVARELLI, M. and VARESIO, L. (2008). Transcriptome of hypoxic immature dendritic cells: modulation of chemokine/receptor expression. Mol Cancer Res. 6: 175-185.
41. SACCANI, A., SCHIOPPA, T., PORTA, C., BISWAS, S. K., NEBULONI, M., VAGO, L., BOTTAZZI, B., COLOMBO, M. P., MANTOVANI, A. and SICA, A. (2006). p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res. 66: 11432-11440.
42. SAUER, H., WARTENBERG, M. and HESCHELER, J. (2001). Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem. 11: 173-186.
43. SESSA, C., GUIBAL, A., DEL CONTE, G. and RUEGG, C. (2008). Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations? Nat Clin Pract Oncol. 5: 378-391.
44. SHOJAEI, F., SINGH, M., THOMPSON, J. D. and FERRARA, N. (2008). Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. Proc Natl Acad Sci USA. 105: 2640-2645.
45. SICA, A., LARGHI, P., MANCINO, A., RUBINO, L., PORTA, C., TOTARO, M. G., RIMOLDI, M., BISWAS, S. K., ALLAVENA, P. and MANTOVANI, A. (2008). Macrophage polarization in tumour progression. Semin Cancer Biol. 18: 349-355.
46. STEINBACH, G., LYNCH, P. M., PHILLIPS, R. K., WALLACE, M. H., HAWK, E., GORDON, G. B., WAKABAYASHI, N., SAUNDERS, B., SHEN, Y., FUJIMURA, T., SU, L. K. and LEVIN, B. (2000). The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 342: 1946-1952.
47. ULRICH, C. M., BIGLER, J. and POTTER, J. D. (2006). Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer. 6: 130-140.
48. VAN DE VEIRE, S., STALMANS, I., HEINDRYCKX, F., OURA, H., TIJERAS-RABALLAND, A., SCHMIDT, T., LOGES, S., ALBRECHT, I., JONCKX, B., et al. (2010). Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell. 141: 178-190.
49. WOOD, J., BONJEAN, K., RUETZ, S., BELLAHCENE, A., DEVY, L., FOIDART, J. M., CASTRONOVO, V. and GREEN, J. R. (2002). Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther. 302: 1055-1061.
50. YOUN, J. I., NAGARAJ, S., COLLAZO, M. and GABRILOVICH, D. I. (2008). Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol. 181: 5791-5802.